We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Breakthrough in Protein Variant Detection Using Nanopore Technology to Advance POC Diagnostics

By LabMedica International staff writers
Posted on 03 Aug 2023
Print article
Image: Nanopore technology has achieved a breakthrough in protein variant detection (Photo courtesy of Oxford Nanopore Technologies)
Image: Nanopore technology has achieved a breakthrough in protein variant detection (Photo courtesy of Oxford Nanopore Technologies)

Human cells hold around 20,000 protein-encoding genes, although the actual number of proteins present in cells far exceeds this figure, with over a million distinct structures known to exist. These variants occur through a procedure known as post-translational modification (PTM), which happens after a protein has been transcribed from DNA. PTM creates structural changes such as adding chemical groups or carbohydrate chains to the individual amino acids that comprise the proteins. As a result, the same protein chain can have hundreds of possible variations. These variants play essential roles in biology, regulating complex biological processes within individual cells. Understanding the variation could greatly enhance our knowledge of cellular functions. However, producing a comprehensive inventory of proteins has so far remained unachievable.

A team of scientists led by the University of Oxford (Oxford, UK) has made a significant breakthrough in identifying variations in protein structures. Their method utilizes cutting-edge nanopore technology to detect structural variations at the single-molecule level, even deep within long protein chains. The researchers successfully devised the protein analysis technique based on nanopore DNA/RNA sequencing technology. In this approach, a directional flow of water captures and unfolds 3D proteins into linear chains that are fed through tiny pores that only permit one amino acid molecule to pass at a time. Structural variations are recognized by measuring fluctuations in an electrical current applied across the nanopore. Each molecule disrupts the current differently, giving them a unique signature.

The team successfully demonstrated the efficacy of this method in detecting three different PTM modifications (phosphorylation, glutathionylation, and glycosylation) at the single-molecule level in protein chains exceeding 1,200 residues. These included modifications deeply embedded within the protein sequence. What is particularly noteworthy is that the method operates without the need for labels, enzymes, or additional reagents. This novel protein characterization technique can be easily integrated into currently available portable nanopore sequencing devices, allowing for the rapid development of protein inventories of single cells and tissues. This could expedite point-of-care diagnostics and facilitate the personalized detection of specific protein variants related to diseases such as cancer and neurodegenerative disorders.

“This simple yet powerful method opens up numerous possibilities. Initially, it allows for the examination of individual proteins, such as those involved in specific diseases,” said Professor Yujia Qing from the Department of Chemistry at the University of Oxford. “In the longer term, the method holds the potential to create extended inventories of protein variants within cells, unlocking deeper insights into cellular processes and disease mechanisms.”

“The ability to pinpoint and identify post-translational modifications and other protein variations at the single-molecule level holds immense promise for advancing our understanding of cellular functions and molecular interactions,” added Professor Hagan Bayley from the Department of Chemistry at the University of Oxford. “It may also open new avenues for personalized medicine, diagnostics, and therapeutic interventions.”

Related Links:
University of Oxford

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Cooling Table Centrifuge
MPW-352R
New
Control Material
Blood Culture Identification Control Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The PAXgene Urine Liquid Biopsy Set is the first standardized preanalytical workflow that stabilizes cell-free DNA in urine for subsequent analysis (Photo courtesy of PreAnalytiX)

Liquid Biopsy Solution Enables Non-Invasive Sample Collection and Direct Cell-Free DNA Stabilization from Urine

Urine cell-free DNA (cfDNA) presents significant potential for research and future clinical applications. It facilitates the measurement and analysis of cfDNA fragments, detection of genetic alterations,... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.